These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 26582961)

  • 21. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.
    Herbert AS; Davidson C; Kuehne AI; Bakken R; Braigen SZ; Gunn KE; Whelan SP; Brummelkamp TR; Twenhafel NA; Chandran K; Walkley SU; Dye JM
    mBio; 2015 May; 6(3):e00565-15. PubMed ID: 26015498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic Cells Generated From
    Edenborough KM; Bokelmann M; Lander A; Couacy-Hymann E; Lechner J; Drechsel O; Renard BY; Radonić A; Feldmann H; Kurth A; Prescott J
    Front Immunol; 2019; 10():2414. PubMed ID: 31681302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.
    Dutta M; Robertson SJ; Okumura A; Scott DP; Chang J; Weiss JM; Sturdevant GL; Feldmann F; Haddock E; Chiramel AI; Ponia SS; Dougherty JD; Katze MG; Rasmussen AL; Best SM
    Cell Rep; 2017 Jan; 18(3):816-829. PubMed ID: 28099857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Challenges of Ebola Virus-Host Dynamics during Infection and Treatment.
    Chertow DS; Shekhtman L; Lurie Y; Davey RT; Heller T; Dahari H
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAM134B, the Selective Autophagy Receptor for Endoplasmic Reticulum Turnover, Inhibits Replication of Ebola Virus Strains Makona and Mayinga.
    Chiramel AI; Dougherty JD; Nair V; Robertson SJ; Best SM
    J Infect Dis; 2016 Oct; 214(suppl 3):S319-S325. PubMed ID: 27511895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
    Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
    Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.
    Strong JE; Wong G; Jones SE; Grolla A; Theriault S; Kobinger GP; Feldmann H
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17982-7. PubMed ID: 18981410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice.
    Lavender KJ; Williamson BN; Saturday G; Martellaro C; Griffin A; Hasenkrug KJ; Feldmann H; Prescott J
    J Infect Dis; 2018 Nov; 218(suppl_5):S409-S417. PubMed ID: 30085162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.
    Whitmer SLM; Ladner JT; Wiley MR; Patel K; Dudas G; Rambaut A; Sahr F; Prieto K; Shepard SS; Carmody E; Knust B; Naidoo D; Deen G; Formenty P; Nichol ST; Palacios G; Ströher U;
    Cell Rep; 2018 Jan; 22(5):1159-1168. PubMed ID: 29386105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.
    Pinsky BA; Sahoo MK; Sandlund J; Kleman M; Kulkarni M; Grufman P; Nygren M; Kwiatkowski R; Baron EJ; Tenover F; Denison B; Higuchi R; Van Atta R; Beer NR; Carrillo AC; Naraghi-Arani P; Mire CE; Ranadheera C; Grolla A; Lagerqvist N; Persing DH
    PLoS One; 2015; 10(11):e0142216. PubMed ID: 26562786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Transcriptional Changes within Liver, Adrenal Gland, and Lymphoid Tissues Significantly Contribute to Ebola Virus Pathogenesis in Cynomolgus Macaques.
    Jankeel A; Menicucci AR; Woolsey C; Fenton KA; Mendoza N; Versteeg K; Cross RW; Geisbert TW; Messaoudi I
    J Virol; 2020 May; 94(11):. PubMed ID: 32213610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever.
    Speranza E; Bixler SL; Altamura LA; Arnold CE; Pratt WD; Taylor-Howell C; Burrows C; Aguilar W; Rossi F; Shamblin JD; Wollen SE; Zelko JM; Minogue T; Nagle E; Palacios G; Goff AJ; Connor JH
    Sci Transl Med; 2018 Mar; 10(434):. PubMed ID: 29593102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.
    Rottstegge M; Tipton T; Oestereich L; Ruibal P; Nelson EV; Olal C; Port JR; Seibel J; Pallasch E; Bockholt S; Koundouno FR; Boré JA; Rodríguez E; Escudero-Pérez B; Günther S; Carroll MW; Muñoz-Fontela C
    J Virol; 2022 Sep; 96(18):e0057422. PubMed ID: 36073921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host Factors Involved in Ebola Virus Replication.
    Rasmussen AL
    Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
    Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
    Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.
    Seesuay W; Jittavisutthikul S; Sae-Lim N; Sookrung N; Sakolvaree Y; Chaicumpa W
    Emerg Microbes Infect; 2018 Mar; 7(1):41. PubMed ID: 29568066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.